Clinical trial
A Multi-center, Open-label, Single-arm, Phase IV Clinical Trial to Evaluate the Preference Regarding Convenience of Medication, Efficacy and Safety After Switching to SUGAMET®XR Tablet 5/1000mg in Patients With Type 2 Diabetes and Renal Diseases
NCT04653779 is registered in ClinicalTrials.gov with Dong-A ST Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Open-label, Single-arm, Phase IV Clinical Trial to Evaluate the Preference Regarding Convenience of Medication, Efficacy and Safety After Switching to SUGAMET®XR Tablet 5/1000mg in Patients With Type 2 Diabetes and Renal Diseases
- Lead sponsor
- Dong-A ST Co., Ltd.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2020
- Completion date
- July 31, 2021
- Enrollment
- 54 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, diabetes mellitus, type 2, endocrine system diseases, metabolic disease, renal disease